In 93 children aged 3-12 with persistent sleep-disordered breathing after 6 weeks of saline, intranasal mometasone furoate did not improve symptom resolution versus continued saline (35.6% vs 36.4%; risk difference -0.9%). Saline run-in alone resolved 29.5%.
RCTn = 93
Nixon et al. Intranasal Treatments for Children With Sleep-Disordered Breathing: The MIST+ Randomized Clinical Trial